Source: Program. Conference titles: Brazil MRS Meeting. Unidade: IFSC
Subjects: NANOCIÊNCIA, NANOTECNOLOGIA, NEOPLASIAS, PLANEJAMENTO DE FÁRMACOS
ABNT
STERMAN, Raquel González et al. Development and validation of a method for simultaneous quantification of erlotinib and doxorubicin in cell membrane-derived nanovesicles. 2023, Anais.. Rio de Janeiro: Sociedade Brasileira de Pesquisa em Materiais - SBPMat, 2023. Disponível em: https://repositorio.usp.br/directbitstream/487a8356-16b0-4a46-b473-d330eb8b9dc5/3159761.pdf. Acesso em: 20 ago. 2024.APA
Sterman, R. G., Cardoso, V. M. de O., Bistaffa, M. J., & Zucolotto, V. (2023). Development and validation of a method for simultaneous quantification of erlotinib and doxorubicin in cell membrane-derived nanovesicles. In Program. Rio de Janeiro: Sociedade Brasileira de Pesquisa em Materiais - SBPMat. Recuperado de https://repositorio.usp.br/directbitstream/487a8356-16b0-4a46-b473-d330eb8b9dc5/3159761.pdfNLM
Sterman RG, Cardoso VM de O, Bistaffa MJ, Zucolotto V. Development and validation of a method for simultaneous quantification of erlotinib and doxorubicin in cell membrane-derived nanovesicles [Internet]. Program. 2023 ;[citado 2024 ago. 20 ] Available from: https://repositorio.usp.br/directbitstream/487a8356-16b0-4a46-b473-d330eb8b9dc5/3159761.pdfVancouver
Sterman RG, Cardoso VM de O, Bistaffa MJ, Zucolotto V. Development and validation of a method for simultaneous quantification of erlotinib and doxorubicin in cell membrane-derived nanovesicles [Internet]. Program. 2023 ;[citado 2024 ago. 20 ] Available from: https://repositorio.usp.br/directbitstream/487a8356-16b0-4a46-b473-d330eb8b9dc5/3159761.pdf